Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
191. |
ECCT/17/03/02 | The Edoxaban Hokusai VTE PEDIATRICS Study A PHASE 3, OPEN-LABEL, RANDOMIZED, MULTICENTER, CONTROLLED TRIAL TO EVALUATE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN AND TO COMPARE THE EFFICACY AND SAFETY OF EDOXABAN WITH STANDARD OF CARE ANTICOAGULANT THERAPY IN PEDIATRIC SUBJECTS FROM BIRTH TO LESS THAN 18 YEARS OF AGE WITH CONFIRMED VENOUS THROMBOEMBOLISM (VTE) |
Principal Investigator(s) 1. Bernhards Ragama Ogutu Ragama Site(s) in Kenya 1. Gertrudes Hospital (Nairobi City county) 2. Mater Hospital (Nairobi City county) |
03-10-2017 |
View |
192. |
ECCT/17/08/02 | IMPROVE (Improving PRegnancy Outcomes with intermittent PReVEntive treatment in Africa) IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi and Tanzania: an international multi-centre 3-arm placebo-controlled trial |
Principal Investigator(s) 1. Simon Kariuki Site(s) in Kenya 1. Migori County Referral Hospital (Migori county) 2. Homa Bay County Referral Hospital (Homa Bay county) 3. Rongo Sub-County Hospital (Migori county) 4. Ahero Sub-County Hospital (Kisumu county) 5. Rabuor Sub-County Hospital (Kisumu county) |
07-09-2017 |
View |
193. |
ECCT/17/03/05 | HOPE Sickle Cell Disease Clinical Study A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease |
Principal Investigator(s) 1. Videlis Nduba 2. Jessie Nyokabi Githanga Site(s) in Kenya 1. Gertrude\'s Children\'s Hospital (Nairobi City county) 2. Strathmore University Medical Center (Nairobi City county) 3. KEMRI CRDR Clinical Research clinic at Chandaria Health Center (Nairobi City county) 4. KEMRI Kondele Childrens Hospital Center for Clinical Research (Kisumu county) 5. KEMRI Clinical Research Center at Siaya County Referral Hospital (Siaya county) |
14-07-2017 |
View |
194. |
ECCT/16/11/03 | COAST Childrens Oxygen Administration Strategies Trial |
Principal Investigator(s) 1. Kathryn Maitland Site(s) in Kenya 1. Kilifi County Hospital (Kilifi county) 2. Coast Provincial General Hospital (Mombasa county) |
22-02-2017 |
View |
195. |
ECCT/16/12/02 | Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial. |
Principal Investigator(s) 1. ISAAC TSIKHUTSU Site(s) in Kenya KEMRI/WRP, KERICHO |
10-01-2017 |
View |
196. |
ECCT/16/08/01 | A5349/TBTC S31 A5349/TBTC S31 “Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial” |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) |
13-12-2016 |
View |
197. |
ECCT/16/07/02 | A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events |
Principal Investigator(s) 1. Mark Loeb Site(s) in Kenya The Aga Khan University Hospital |
17-08-2016 |
View |
198. |
ECCT/16/06/02 | A5263: A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings |
Principal Investigator(s) 1. Vincent Oliver Otieno Site(s) in Kenya 1. Kisumu CRS (Kisumu county) |
28-07-2016 |
View |
199. |
ECCT/15/08/01 | Rifapentine During Intensive Phase TB Treatment Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial |
Principal Investigator(s) 1. Elisha Ochieng Okeyo Site(s) in Kenya KEMRICDC, KISUMU, KENYA |
05-05-2016 |
View |
200. |
ECCT/15/11/01 | A5264 A Randomized Evaluation of Antiretroviral Therapy Alone or with Delayed Chemotherapy versus Antiretroviral Therapy with Immediate Adjunctive Chemotherapy for Treatment of Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS) |
Principal Investigator(s) 1. Dr. Victor Otieno Mudhune Site(s) in Kenya 1. KEMRI CDC (Kisumu county) |
05-05-2016 |
View |